New Jersey S 1729: Places $100 cap on amount paid by covered persons for purchase of insulin drugs; requires Division of Consumer Affairs to investigate insulin prices.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2020-02-13)

State: New Jersey · Session: 219 · Bill: S 1729

Subjects: CONSUMER PRO, DISEASE, HEALTH INSUR, PHARMACEUTIC

Sponsors: Lagana, Joseph A.

View New Jersey S 1729 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.